Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... said. "The issue is always timing - when to start antioxidant interventions at what combination and what dose."Caloric restriction, another way to reduce oxidative damage, ... in humans."Keywords: Aging, Audiology, Hearing Loss, Otolaryngology, Therapy, Treatment, University of Florida.This article was prepared by NewsRx Health ...
2009 NOV 24 ... and information on all that defines this unique destination. Featuring an unprecedented combination of striking architecture, sustainable design, high-end service and spectacular ... poolside spa cabanas and Las Vegas' first co-ed spa balcony, featuring an outdoor therapy pool and views of ARIA's spectacular poolscape. In addition to skincare and massage ...
2009 NOV 27 ... for the synthesis of five C-nucleoside phosphoramidite derivatives that, when used in combination, provide strategies for probing the potential functional role of cytosine's keto group ... Country:United States, City:Chicago, State:IL, Country:United States, Life Sciences, Therapy, Treatment, Nucleoside Analog, Organic Chemistry.This article was prepared ...
2009 NOV 28 ... support its potential as a highly potent, once-a-day oral therapy highly amenable to combination with other anti-virals for the treatment of patients with chronic hepatitis C infection. ...
2009 NOV 27 ... the cytoplasm, was insignificant; however, it was enhanced if cycloheximide was added in combination with lincomycin. The autophagy inhibitor 3-methyladenine removed the chitosan effect but ... Country:Russia, Life Sciences, Apoptosis, Mannitol, Pharmaceuticals, Drugs, Therapy, Treatment, Biochemistry, Biochemical Sciences, Lomonosov Moscow State ...
2009 NOV 27 ... other 43 patients were treated with prednisolone for 2 weeks plus G biloba for 4 weeks (combination therapy). All patients used mometasone nasal spray twice daily for 4 weeks. Scores on the BTT ...
2009 NOV 28 ... disorder, and with behaviors such as tantrums, aggression, self-injurious behavior, or a combination of these symptoms, were randomized 1:1:1:1 to aripiprazole (5, 10, or 15 mg/day) or ... Pharmaceutical Business, Pharmaceutical Company, Aripiprazole, Pharmaceuticals, Drugs, Therapy, Treatment, Psychiatry, Bristol-Myers Squibb Company.This article was ...
2009 NOV 24 ... Lv and colleagues. The researchers concluded: "Vanadium at lower doses in combination with C. comatus induced significant effect on glycemic metabolism in mice." ... Country:People's Republic of China, Life Sciences, Copper, Pharmaceuticals, Drugs, Therapy, Treatment, Metabolism, Trace Element Research. This article was prepared ...
2009 NOV 27 ... hydrogen-bonding constraints introduced by the His64 -> Lys substitution, as well as a combination of hydrophobic effect and the removal of unfavorable electrostatic interactions through ... City:Erlangen, Country:Germany, Life Sciences, Bioengineering, Biotechnology, Therapy, Treatment, Tetracycline, Biochemistry, University of Erlangen.This article ...
2009 NOV 24 ... the authors conclude. "Improvements in quality of care will likely require a combination of investments in systems such as electronic health records, greater use of other ... in which patients did not receive these services, while providing appropriate medication therapy was not associated with longer visit duration. "Although it is possible ...
2009 NOV 23 ... and Strategic Account Management effort for Hackett. "The Archstone - Hackett combination offers our clients a significantly expanded set of offerings along with our rich ... Audio, Acquisitions, Asia, Economics, Mergers, Offshoring, Technology, Pharmaceuticals, Therapy, Treatment This article was prepared by Biotech Business Week editors from ...
2009 NOV 23 ... U.S. Department of Defense (DOD) to conduct an animal study of the use of vigabatrin in combination with opiates to effectively manage pain while reducing the potential for opiate ... Marketing and Licensing Agreements, Mental Health, Pharmaceuticals, Psychiatry, Therapy, Treatment, Vigabatrin, Catalyst Pharmaceutical Partners. This article was ...
2009 NOV 23 ... approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are ... Genetics, Genomics, Marketing and Licensing Agreements, Oncology, RNA Research, Therapy, Treatment, Life Technologies Corporation. This article was prepared by ...
2009 NOV 23 ... a PCV < 25%, and 760 days for cats with a PCV >= 25% (P=0.017). Radiation therapy in combination with surgery results in relatively long-term survival in cats with soft tissue ...
2009 NOV 23 ... & Co. to assist in evaluating its strategic alternatives. These alternatives include any combination of a restructuring of the Company and its debt and a sale of the Company or its assets. ... FDA, Oncology, Pharmaceutical Business, Pharmaceutical Company, Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Vion Pharmaceuticals Inc., Vion ...
2009 NOV 28 ... changes. The adjustments will be necessary to provide the Fellows with the best combination of content knowledge and classroom expertise to most effectively address the challenges ... Education, Technology, Commit, Drugs, Nicotine Polacrilex, Pediatrics, Pharmaceuticals, Therapy, Treatment, W.K. Kellogg Foundation.This article was prepared by Pediatrics ...
2009 NOV 29 ... scoured the genome to determine which genes are targeted by human FOXP2. The team used a combination of human cells, human tissue and post-mortem brain tissue from chimps that died of ... Disabilities, Drug Development, Neurology, Psychiatry, Schizophrenia, Speech, Therapy, Treatment, University of California - Los Angeles.This article was prepared ...
2009 NOV 23 ... to doxorubicin (the only currently FDA-approved agent in sarcoma) or to palifosfamide in combination with doxorubicin. As of the October 5th cut-off date, there were 67 patients randomized ... Sunitinib Maleate, Sutent, Synovial Sarcoma, Testicular Cancer, Testicular Diseases, Therapy, Treatment, U.S. Food and Drug Administration, Urology, ZIOPHARM Oncology Inc. ...
2009 NOV 23 ... in cancer patients, oral indibulin has been administered both as a single agent and in combination with favorable activity and a promising safety profile that does not include the ... Pre-Trials Research, Regulatory Actions, Sarcoma, Soft Tissue Sarcoma, Therapies, Therapy, Treatment, U.S. Food and Drug Administration, Women's Health, ZIOPHARM Oncology Inc. ...
